WeightWatchers Gets a Makeover With Obesity-Drug Business

If you can’t beat them, join them.

WeightWatchers ’ acquisition of the drug-prescribing business Sequence, which closed last Monday, is a clear sign that the center of gravity in the weight-loss industry is shifting. Whereas conventional wisdom for decades was that obesity could only be addressed through lifestyle changes, powerful new drugs are starting to change that narrative, forcing the old guard to adapt or die.